...
首页> 外文期刊>BMC Nephrology >Online hemodiafilteration use in children: a single center experience with a twist
【24h】

Online hemodiafilteration use in children: a single center experience with a twist

机译:在线血液摩擦使用儿童:单一的中心经验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND:Haemodiafilteration (HDF) is a promising new modality of renal replacement therapy (RRT). It is an improvement in the quality of hemodialysis (HD) and thus in the quality of patients'lives. The main obstacle to using HDF is the cost, especially in developing countries. The purpose of this study was to evaluate the benefits of incorporating HDF with different regimens in the treatment of children with end stage renal disease (ESRD).METHODS:Thirty-four children with ESRD on regular HD in Pediatric Dialysis Unit, Children's Hospital, Ain Shams University were followed up in 2 phases: initial phase (all patients: HD thrice weekly for 3?months) and second phase, patients were randomized into 2 groups, HDF group and HD group, the former was subdivided into once and twice weekly HDF subgroups. Evaluation using history, clinical and laboratory parameters at 0, 3, 9 and 18?months was carried out.RESULTS:On short term, we found that the HDF group was significantly superior to HD group regarding all clinical and laboratory parameters. Also, twice HDF subgroup was significantly superior to once HDF subgroup. This was confirmed on long term follow up, but the once HDF proved comparable to twice subgroup.CONCLUSIONS:Incorporating online hemodiafilteration (OL-HDF) in the RRT of children was beneficial in most of the clinical and laboratory parameters measured. It's not all or non; OL-HDF, even once a week, can improve outcomes of HD without significantly affecting the cost.
机译:背景:血红蛋白(HDF)是一个有前途的肾替代治疗方式(RRT)。它是血液透析(HD)质量的改善,从而提高患者的质量。使用HDF的主要障碍是成本,特别是在发展中国家。本研究的目的是评估将HDF与不同方案的益处掺入患有末期肾病(ESRD)的儿童(ESRD)。方法:三十四个儿童在儿科透析单位,儿童医院,AIN常规HD。 Shams大学出现在2个阶段:初始阶段(所有患者:HD每周三个月的HD三个月)和第二阶段,患者被随机分为2组,HDF组和HD组,前者被细分为每周两次HDF子组。使用历史,临床和实验室参数评估0,3,9和18岁以下的月份。结果:短期:在短期内,我们发现HDF组关于所有临床和实验室参数明显优于高清组。此外,两次HDF子组明显优于一旦HDF子组。这是长期随访证实的,但曾经的HDF被证明是与两次亚组相当的。结论:在患儿RRT中纳入在线血液透射率(OL-HDF)在大多数临床和实验室参数中有益。这不是全部或非全部; OL-HDF,即使是每周一次,也可以改善HD的结果,而不会显着影响成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号